Clinical Trial Update: Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE) [Phase 2, Phase 3]

View source ↗

Summary

Clinical update on the TRAPPE trial evaluating a reduced dose of alteplase for parapneumonic effusion (pleural infection); the study is in Phase 2/Phase 3 and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parapneumonic Effusion
• Pleural Infection

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Pleural Infection | Phase 2, Phase 3 | Status: RECRUITING